Modified coagulation factors with prolonged in vivo half-life

Details for Australian Patent Application No. 2007338298 (hide)

Owner CSL Behring GmbH

Inventors Schulte, Stefan; Weimer, Thomas; Metzner, Hubert

Agent Watermark

Pub. Number AU-A-2007338298

PCT Pub. Number WO2008/077616

Priority 60/879,334 09.01.07 US; 06026747.3 22.12.06 EP

Filing date 21 December 2007

Wipo publication date 3 July 2008

International Classifications

A61K 38/37 (2006.01) Medicinal preparations containing peptides

A61K 38/38 (2006.01) Medicinal preparations containing peptides - Albumins

C07K 14/755 (2006.01) Peptides having more than 20 amino acids

C07K 14/76 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/077616 Priority application(s): WO2008/077616

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007338305-Inhalation device for drugs in powder form

2007338275-Hair-conditioning agents containing selected cationic polymers and watersoluble silicones